InvestSMART

AFT Pharmaceuticals Limited (ASX: AFP) - Announcements

- Current share price for AFP : $3.870

ASX company news and announcements for AFT Pharmaceuticals Limited (AFP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All AFT Pharmaceuticals Limited (AFP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than AFT Pharmaceuticals Limited (AFP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for AFT Pharmaceuticals Limited (AFP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$406 AFT welcomes new codeine medicine restrictions 5 Dec 2019 7:33AM $2.910 $3.870 risen by 32.99%
$406 Letter to Shareholders 26 Nov 2019 9:13AM $2.900 $3.870 risen by 33.45%
$406 Half Yearly Report and Accounts 21 Nov 2019 7:31AM $2.680 $3.870 risen by 44.40%
$406 Half Yearly Report and Accounts 21 Nov 2019 7:30AM $2.680 $3.870 risen by 44.40%
$406 Half Yearly Report and Accounts 21 Nov 2019 7:30AM $2.680 $3.870 risen by 44.40%
$406 Half Yearly Report and Accounts 21 Nov 2019 7:30AM $2.680 $3.870 risen by 44.40%
$406 AFT signs agreements to new markets worth more than US$ 1 b 18 Nov 2019 7:31AM $2.660 $3.870 risen by 45.49%
$406 Letter to Shareholders 4 Nov 2019 7:30AM $2.800 $3.870 risen by 38.21%
$406 Letter to Shareholders 11 Oct 2019 7:31AM $2.800 $3.870 risen by 38.21%
$406 AFT and SETEK sign medicinal cannabis MoU 8 Oct 2019 7:33AM $2.800 $3.870 risen by 38.21%
$406 Amended Constitution 4 Sep 2019 9:36AM $2.960 $3.870 risen by 30.74%
$406 Results of Meeting 2 Aug 2019 10:30AM $2.960 $3.870 risen by 30.74%
$406 Annual Meeting - Presentation 2 Aug 2019 7:52AM $2.960 $3.870 risen by 30.74%
$406 Annual Meeting - Chairman's Address 2 Aug 2019 7:49AM $2.960 $3.870 risen by 30.74%
$406 AFT Achieves first registration of patented painkiller 24 Jul 2019 7:31AM $3.090 $3.870 risen by 25.24%
$406 Licensing Agreement for Pascomer in North America 5 Jul 2019 7:32AM $2.910 $3.870 risen by 32.99%
$406 Proxy Form 3 Jul 2019 8:14AM $2.910 $3.870 risen by 32.99%
$406 Notice of Annual General Meeting 3 Jul 2019 8:14AM $2.910 $3.870 risen by 32.99%
$406 Letter to Shareholders 20 Jun 2019 9:05AM $2.920 $3.870 risen by 32.53%
$406 Annual Meeting and Closing Date for Director Nominations 4 Jun 2019 8:08AM $2.500 $3.870 risen by 54.80%
$406 Annual Report to shareholders 22 May 2019 2:54PM $2.450 $3.870 risen by 57.96%
$406 Investor Presentation - May 2019 22 May 2019 7:31AM $2.400 $3.870 risen by 61.25%
$406 Annual Report to shareholders 22 May 2019 7:31AM $2.400 $3.870 risen by 61.25%
$406 Preliminary Final Report 22 May 2019 7:31AM $2.400 $3.870 risen by 61.25%
$406 Audited Financial Results for the Year to 31 March 2019 22 May 2019 7:30AM $2.400 $3.870 risen by 61.25%

301 - 325 of 546 results

Page 13 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.